Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Blood Cancer Journal
|
May 3, 2023
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, et al.
Nature Communications
|
July 7, 2025
Low-noise frequency synthesis and terahertz wireless communication driven by compact turnkey Kerr combs
Kunpeng Jia, Yuancheng Cai, Xinwei Yi, et al.
Cytotherapy
|
April 3, 2026
Donor- and patient-derived interleukin 6 knockdown CD19-targeted chimeric antigen receptor T cells exhibit similar efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia patients after allogeneic hematopoietic stem cell transplantation
Ting Sun, Jin-Feng Ma, Xu Jia, et al.
Neuroscience Bulletin
|
January 16, 2013
Ventral medial prefrontal functional connectivity and emotion regulation in chronic schizophrenia: a pilot study
Feng-Mei Fan, Shu-Ping Tan, Fu-De Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 29, 2005
Cancer chemotherapy and drug metabolism
David S Riddick, Chunja Lee, Shairoz Ramji, et al.
Schizophrenia Research
|
October 22, 2011
Dysfunction in different phases of working memory in schizophrenia: evidence from ERP recordings
Yan Li Zhao, Shu Ping Tan, Fu De Yang, et al.
Frontiers in Oncology
|
September 20, 2021
A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia
Jia Yin, Chao-Ling Wan, Ling Zhang, et al.
Clinical Epigenetics
|
October 14, 2025
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCT
Ya-Xue Wu, Chao-Ling Wan, Kai-Wen Tan, et al.
Blood Advances
|
March 10, 2023
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
Li-Yun Chen, Wen-Jie Gong, Ming-Hao Li, et al.
Cancer
|
November 7, 2025
A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia
Chong-Sheng Qian, Zi-Hao Wang, Zheng Li, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Blood Cancer Journal
|
May 3, 2023
Safety and efficacy of CD22 and CD19 CAR-T bridging auto-HSCT as consolidation therapy for AYA and adult B-ALL
Yan Qiu, Chao-Ling Wan, Ming-Zhu Xu, et al.
Nature Communications
|
July 7, 2025
Low-noise frequency synthesis and terahertz wireless communication driven by compact turnkey Kerr combs
Kunpeng Jia, Yuancheng Cai, Xinwei Yi, et al.
Cytotherapy
|
April 3, 2026
Donor- and patient-derived interleukin 6 knockdown CD19-targeted chimeric antigen receptor T cells exhibit similar efficacy and safety in treating relapsed B-cell acute lymphoblastic leukemia patients after allogeneic hematopoietic stem cell transplantation
Ting Sun, Jin-Feng Ma, Xu Jia, et al.
Neuroscience Bulletin
|
January 16, 2013
Ventral medial prefrontal functional connectivity and emotion regulation in chronic schizophrenia: a pilot study
Feng-Mei Fan, Shu-Ping Tan, Fu-De Yang, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
July 29, 2005
Cancer chemotherapy and drug metabolism
David S Riddick, Chunja Lee, Shairoz Ramji, et al.
Schizophrenia Research
|
October 22, 2011
Dysfunction in different phases of working memory in schizophrenia: evidence from ERP recordings
Yan Li Zhao, Shu Ping Tan, Fu De Yang, et al.
Frontiers in Oncology
|
September 20, 2021
A Phase II Trial of the Double Epigenetic Priming Regimen Including Chidamide and Decitabine for Relapsed/Refractory Acute Myeloid Leukemia
Jia Yin, Chao-Ling Wan, Ling Zhang, et al.
Clinical Epigenetics
|
October 14, 2025
Phase II study of dual epigenetic targeting with chidamide and azacitidine in patients with high-risk acute myeloid leukemia after allo-HSCT
Ya-Xue Wu, Chao-Ling Wan, Kai-Wen Tan, et al.
Blood Advances
|
March 10, 2023
Anti-CD19 CAR T-cell consolidation therapy combined with CD19+ feeding T cells and TKI for Ph+ acute lymphoblastic leukemia
Li-Yun Chen, Wen-Jie Gong, Ming-Hao Li, et al.
Cancer
|
November 7, 2025
A phase 2 trial of a "sandwich" strategy: Sequential CD22/CD19 chimeric antigen receptor T-cells therapy combined with autologous hematopoietic stem cell transplantation in patients with Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia
Chong-Sheng Qian, Zi-Hao Wang, Zheng Li, et al.
Page
of 9